text
"['\n2. 연결재무제표\n(1) 연결재무상태표\n연\xa0\xa0 결\xa0\xa0 재\xa0\xa0 무\xa0\xa0 상\xa0\xa0 태\xa0\xa0 표\n제 64 기\xa0 :\xa0 2019년 12월 31일 현재\n제 63 기\xa0 :\xa0 2018년 12월 31일 현재\n제 62 기\xa0 :\xa0 2017년 12월 31일 현재\n삼성생명보험주식회사와 그 종속기업\n(단위 : 백만원)\n과\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 목\n제 64 (당) 기\n제 63 (전) 기\n제 62 (전전) 기\n\xa0Ⅰ.현금및현금성자산(주석 9,37)\n5,207,649\n3,434,345\xa0\n4,055,552\xa0\n\xa0Ⅱ.당기손익인식금융자산(주석 4,9)\n4,072,253\n3,488,145\xa0\n2,861,654\xa0\n\xa0Ⅲ.매도가능금융자산(주석 5,9)\n166,997,576\n147,638,963\xa0\n146,042,900\xa0\n\xa0Ⅳ.만기보유금융자산(주석 6,9)\n280,147\n280,873\xa0\n297,696\xa0\n\xa0V.대출채권및기타수취채권(주석 7,9)\n71,754,486\n73,182,513\xa0\n67,072,166\xa0\n\xa0Ⅵ.위험회피목적파생상품자산(주석 8,9)\n561,431\n710,094\xa0\n689,402\xa0\n\xa0Ⅶ.관계기업투자(주석 10)\n1,379,148\n1,346,611\xa0\n1,629,010\xa0\n\xa0Ⅷ.금융리스채권(주석 7,9)\n237,508\n376,524\xa0\n559,238\xa0\n\xa0IX.매각예정자산(주석 41)\n98,637\n-\n49,691\xa0\n\xa0X.투자부동산(주석 11)\n6,448,735\n7,297,969\xa0\n6,812,422\xa0\n\xa0XI.유형자산(주석 12)\n735,119\n822,577\xa0\n1,065,818\xa0\n\xa0XII.무형자산(주석 13)\n743,372\n850,605\xa0\n1,004,315\xa0\n\xa0XIII.사용권자산(주석 40)\n206,188\n-\n-\n\xa0XIV.당기법인세자산\n527,715\n1,187\xa0\n543,749\xa0\n\xa0XV.이연법인세자산(주석 20)\n1,012\n991\xa0\n765\xa0\n\xa0XVI.기타자산(주석 14)\n3,715,998\n4,062,368\xa0\n4,705,774\xa0\n\xa0XVII.특별계정자산(주석 15)\n49,795,298\n45,933,890\xa0\n45,323,665\xa0\n자\xa0 \xa0 \xa0\xa0 산\xa0 \xa0 \xa0\xa0 총\xa0 \xa0 \xa0\xa0 계\n312,762,272==================\n289,427,655 ==================\n282,713,817 ==================\nⅠ.보험계약부채(주석 16)\n180,492,968\n173,943,448\xa0\n166,897,872\xa0\nⅡ.계약자지분조정(주석 18)\n11,528,465\n8,208,565\xa0\n9,599,619\xa0\nⅢ.당기손익인식금융부채(주석 9,19)\n139,237\n19,419\xa0\n15,441\xa0\nⅣ.기타금융부채(주석 9,19)\n20,377,319\n22,484,393\xa0\n19,663,333\xa0\nⅤ.위험회피목적파생상품부채(주석 8,9)\n455,285\n266,692\xa0\n239,429\xa0\nⅥ.당기법인세부채\n138,986\n363,813\xa0\n78,715\xa0\nⅦ.이연법인세부채(주석 20)\n7,850,375\n5,293,854\xa0\n6,668,710\xa0\nⅧ.충당부채(주석 21)\n251,896\n335,416\xa0\n239,350\xa0\nⅨ.기타부채(주석 22)\n1,067,791\n1,029,980\xa0\n1,009,339\xa0\nX.특별계정부채(주석 15)\n53,143,545\n46,976,616\xa0\n47,180,437\xa0\n부\xa0 \xa0 \xa0\xa0 채\xa0 \xa0 \xa0\xa0 총\xa0 \xa0 \xa0\xa0 계\n275,445,867\n258,922,196\xa0\n251,592,245\xa0\nⅠ.지배기업지분\n35,667,037\n28,902,094\xa0\n29,358,947\xa0\n\xa0 1.자본금(주석 23)\n100,000\n100,000\xa0\n100,000\xa0\n\xa0 2.자본잉여금(주석 23)\n125,115\n125,115\xa0\n63,084\xa0\n\xa0 3.자본조정(주석 23)\n(2,116,955)\n(2,116,955)\n(2,116,955)\xa0\n\xa0 4.기타포괄손익누계액(주석 23)\n21,509,453\n15,245,998\xa0\n17,073,526\xa0\n\xa0 5.이익잉여금(주석 23)\n16,049,424\n15,547,936\xa0\n14,239,292\xa0\nⅡ.비지배지분\n1,649,368\n1,603,365\xa0\n1,762,625\xa0\n자\xa0 \xa0 \xa0\xa0 본\xa0 \xa0 \xa0\xa0 총\xa0 \xa0 \xa0\xa0 계\n37,316,405\n30,505,459\xa0\n31,121,572\xa0\n부\xa0\xa0 채\xa0\xa0 와\xa0\xa0 자\xa0\xa0 본\xa0\xa0 총\xa0\xa0 계\n312,762,272 ==================\n289,427,655 ==================\n282,713,817 ==================\n(2) 연결포괄손익계산서\n연\xa0\xa0 결\xa0\xa0\xa0포\xa0\xa0 괄\xa0\xa0 손\xa0\xa0 익\xa0\xa0 계\xa0\xa0 산\xa0\xa0 서\n제 64 기\xa0 :\xa0 2019년 1월 1일부터 2019년 12월 31일까지\n제 63 기\xa0 :\xa0 2018년 1월 1일부터 2018년 12월 31일까지\n제 62 기\xa0 :\xa0 2017년 1월 1일부터 2017년 12월 31일까지\n삼성생명보험주식회사와 그 종속기업\n(단위 : 백만원)\n과\xa0 \xa0 \xa0 \xa0 \xa0 목\n제 64 (당) 기\n제 63 (전) 기\n제 62 (전전) 기\nⅠ.영업수익\n31,804,022\n32,240,885\xa0\n31,959,034\n\xa0 1.보험료수익(주석 24)\n16,201,074\n16,134,974\xa0\n16,645,815\n\xa0 2.재보험수익(주석 25)\n389,855\n340,144\xa0\n301,546\n\xa0 3.이자수익(주석 26)\n7,187,838\n7,109,193\xa0\n6,803,907\n\xa0 4.당기손익인식금융자산관련이익(주석 27)\n722,857\n555,479\xa0\n522,882\n\xa0 5.매도가능금융자산관련이익(주석 27)\n275,872\n1,247,110\xa0\n96,079\n\xa0 6.위험회피목적파생상품관련이익(주석 27)\n144,161\n290,112\xa0\n1,214,034\n\xa0 7.외환거래이익\n811,654\n640,649\xa0\n420,593\n\xa0 8.수수료수익\n1,680,886\n1,677,177\xa0\n2,235,539\n\xa0 9.배당금수익\n1,051,509\n1,081,956\xa0\n791,569\n\xa0 10.임대료수익(주석 11)\n450,122\n420,851\xa0\n413,564\n\xa0 11.특별계정수입수수료\n1,626,473\n1,653,367\xa0\n1,568,717\n\xa0 12.특별계정수익(주석 15)\n523,644\n478,535\xa0\n468,265\n\xa0 13.기타영업수익(주석 28)\n409,730\n271,435\xa0\n191,221\n\xa0 14.리스수익\n328,347\n339,903\xa0\n285,303\n\xa0Ⅱ.영업비용\n30,551,441\n29,657,574\xa0\n30,268,428\n\xa0\xa0 1.책임준비금전입액(주석 16)\n6,003,799\n6,447,570\xa0\n7,625,987\n\xa0\xa0 2.지급보험금\n14,467,397\n13,510,288\xa0\n11,909,948\n\xa0\xa0 3.재보험비용(주석 25)\n443,585\n389,497\xa0\n339,230\n\xa0\xa0 4.사업비(주석 29)\n2,176,339\n2,231,879\xa0\n1,764,161\n\xa0\xa0 5.신계약비상각비(주석 14)\n1,441,454\n1,556,301\xa0\n1,967,010\n\xa0\xa0 6.재산관리비(주석 30)\n297,321\n327,313\xa0\n333,391\n\xa0\xa0 7.이자비용\n636,789\n442,153\xa0\n445,020\n\xa0\xa0 8.당기손익인식금융자산관련손실(주석 27)\n596,905\n416,293\xa0\n370,233\n\xa0\xa0 9.매도가능금융자산관련손실(주석 27)\n60,872\n10,486\xa0\n60,859\n\xa0\xa0 10.대출채권및기타수취채권관련손실(주석 27)\n440,105\n399,371\xa0\n291,292\n\xa0\xa0 11.위험회피목적파생상품관련손실(주석 27)\n625,671\n478,883\xa0\n359,291\n\xa0\xa0 12.외환거래손실\n230,004\n365,329\xa0\n1,419,784\n\xa0\xa0 13.특별계정비용(주석 15)\n523,644\n478,535\xa0\n468,265\n\xa0\xa0 14.기타영업비용(주석 28)\n2,607,556\n2,603,676\xa0\n2,913,957\n\u3000\n\u3000\nⅢ.영업이익\n1,252,581\n2,583,311\xa0\n1,690,606\n\u3000\n\u3000\nⅣ.영업외수익(주석 28)\n211,824\n364,121\xa0\n178,496\n\u3000\n\u3000\nⅤ.영업외비용(주석 28)\n37,616\n581,731\xa0\n186,330\n\u3000\n\u3000\nⅥ.법인세비용차감전연결순이익\n1,426,789\n2,365,701\xa0\n1,682,772\nⅦ.법인세비용(주석 31)\n375,097\n631,991\xa0\n419,565\nⅧ.당기연결순이익\n1,051,692\n1,733,710\xa0\n1,263,207\nⅨ.법인세비용차감후기타포괄손익\n6,269,724\n(1,849,565)\n1,781,097\n\xa0 1. 후속적으로 당기손익으로 재분류될 수 있는 항목\n\xa0 \xa0 가.매도가능금융자산평가손익\n6,200,063\n(2,039,534)\n1,840,459\xa0\n\xa0 \xa0 나.만기보유금융자산평가손익\n-\n(16)\n(186)\n\xa0 \xa0 다.위험회피목적파생상품평가손익\n(37,789)\n146,675\xa0\n(27,878)\n\xa0 \xa0 라.관계기업의 기타포괄손익지분\n10,771\n2,387\xa0\n3,918\xa0\n\xa0 \xa0 마.특별계정기타포괄손익\n97,423\n45,544\xa0\n(36,173)\n\xa0 \xa0 바.해외사업환산손익\n28,352\n15,102\xa0\n(12,775)\n\xa0 2. 당기손익으로 재분류되지 않는 항목\n\u3000\n\u3000\n\xa0 \xa0 가.순확정급여부채의 재측정요소\n(29,096)\n(19,723)\n13,732\n\u3000\n\u3000\nⅩ.당기연결총포괄이익\n7,321,416\n(115,855)\n3,044,304\n\u3000\n\u3000\n\xa0\xa0 1.당기연결순이익의 귀속\n1,051,692\n1,733,710\xa0\n1,263,207\n\xa0 \xa0 \xa0 지배기업의소유지분\n977,391\n1,664,382\xa0\n1,166,121\n\xa0 \xa0 \xa0 비지배지분\n74,301\n69,328\xa0\n97,086\n\u3000\n\u3000\n\xa0\xa0 2.당기연결총포괄이익의 귀속\n7,321,416\n(115,855)\n3,044,304\n\xa0 \xa0 \xa0 지배기업의소유지분\n7,240,846\n(163,146)\n2,929,387\n\xa0 \xa0 \xa0 비지배지분\n80,570\n47,291\xa0\n114,917\n\u3000\n\u3000\nXI.지배기업지분에대한\xa0 \xa0 주당이익(단위: 원)(주석 34)\n\u3000\n\u3000\n\u3000\n\u3000\n\xa0 기본주당이익\n5,443\n9,268\xa0\n6,494\n\xa0 희석주당이익\n5,443\n9,268\xa0\n6,494\n(3) 연결자본변동표\n연\xa0\xa0 결\xa0\xa0 자\xa0\xa0 본\xa0\xa0 변\xa0\xa0 동\xa0\xa0 표\n제64기 :\xa0 2019년 01월 01일부터 2019년 12월 31일까지\n제63기 :\xa0 2018년 01월 01일부터 2018년 12월 31일까지\n제62기\xa0 :\xa0 2017년 01월 01일부터 2017년 12월 31일까지\n삼성생명보험주식회사와 그 종속기업\n(단위 : 백만원)\n과\xa0 목\n지배기업 소유지분\n비지배지분\n총 계\n자본금\n자본잉여금\n자본조정\n기타포괄손익누계액\n이익잉여금\n지배기업소유지분소 계\n2017. 1.1 (전전기초)\n100,000\n63,084\n(2,117,768)\n15,310,260\n13,288,661\n26,644,237\n1,664,211\n28,308,448\nⅠ.당기연결총포괄손익\n\xa0\xa0 1.당기연결순이익\n-\n-\n-\n-\n1,166,121\n1,166,121\n97,086\n1,263,207\n\xa0\xa0 2.매도가능금융자산평가손익\n-\n-\n-\n1,826,723\n-\n1,826,723\n13,736\n1,840,459\n\xa0\xa0 3.만기보유금융자산평가손익\n-\n-\n-\n(186)\n-\n(186)\n-\n(186)\n\xa0\xa0 4.위험회피목적파생상품평가손익\n-\n-\n-\n(32,331)\n-\n(32,331)\n4,453\n(27,878)\n\xa0\xa0 5.관계기업의기타포괄손익\n-\n-\n-\n3,918\n-\n3,918\n-\n3,918\n\xa0\xa0 6.특별계정기타포괄손익\n-\n-\n-\n(36,173)\n-\n(36,173)\n-\n(36,173)\n\xa0\xa0 7.해외사업환산손익\n-\n-\n-\n(11,353)\n-\n(11,353)\n(1,422)\n(12,775)\n\xa0\xa0 8.순확정급여부채재측정요소\n-\n-\n-\n12,668\n-\n12,668\n1,064\n13,732\nⅡ.자본에 직접 인식된 내역\n\xa0\xa0 1.연차배당\n-\n-\n-\n-\n(215,490)\n(215,490)\n(39,528)\n(255,018)\n\xa0\xa0 2.유상증자\n-\n-\n813\n-\n-\n813\n23,025\n23,838\n2017. 12.31 (전전기말)\n100,000==========\n63,084==========\n(2,116,955)==========\n17,073,526==========\n14,239,292==========\n29,358,947==========\n1,762,625==========\n31,121,572==========\n2018. 1.1 (전기초)\n100,000\n63,084\n(2,116,955)\n17,073,526\n14,239,292\n29,358,947\n1,762,625\n31,121,572\n회계정책변경효과\n-\n-\n-\n-\n2,949\n2,949\n-\n2,949\n수정후 금액\n100,000\n63,084\n(2,116,955)\n17,073,526\n14,242,241\n29,361,896\n1,762,625\n31,124,521\nⅠ.당기연결총포괄손익\n\xa0\xa0 1.당기연결순이익\n-\n-\n-\n-\n1,664,382\n1,664,382\n69,328\n1,733,710\n\xa0\xa0 2.매도가능금융자산평가손익\n-\n-\n-\n(2,031,781)\n-\n(2,031,781)\n(7,753)\n(2,039,534)\n\xa0\xa0 3.만기보유금융자산평가손익\n-\n-\n-\n(16)\n-\n(16)\n-\n(16)\n\xa0\xa0 4.위험회피목적파생상품평가손익\n-\n-\n-\n160,142\n-\n160,142\n(13,467)\n146,675\n\xa0\xa0 5.관계기업의기타포괄손익\n-\n-\n-\n2,387\n-\n2,387\n-\n2,387\n\xa0\xa0 6.특별계정기타포괄손익\n-\n-\n-\n45,544\n-\n45,544\n-\n45,544\n\xa0\xa0 7.해외사업환산손익\n-\n-\n-\n14,683\n-\n14,683\n419\n15,102\n\xa0\xa0 8.순확정급여부채재측정요소\n-\n-\n-\n(18,487)\n-\n(18,487)\n(1,236)\n(19,723)\nⅡ.자본에 직접 인식된 내역\n\xa0\xa0 1.연차배당\n-\n-\n-\n-\n(359,150)\n(359,150)\n(39,528)\n(398,678)\n\xa0\xa0 2.지분법이익잉여금변동\n-\n-\n-\n-\n463\n463\n-\n463\n\xa0\xa0 3.기타\n-\n62,031\n-\n-\n-\n62,031\n(167,023)\n(104,992)\n2018. 12.31 (전기말)\n100,000==========\n125,115==========\n(2,116,955)==========\n15,245,998==========\n15,547,936==========\n28,902,094==========\n1,603,365==========\n30,505,459==========\n2019. 1.1 (당기초)\n100,000\n125,115\n(2,116,955)\n15,245,998\n15,547,936\n28,902,094\n1,603,365\n30,505,459\nⅠ.당기연결총포괄손익\n\xa0\xa0 1.당기연결순이익\n-\n-\n-\n-\n977,391\n977,391\n74,301\n1,051,692\n\xa0\xa0 2.매도가능금융자산평가손익\n-\n-\n-\n6,187,559\n-\n6,187,559\n12,504\n6,200,063\n\xa0\xa0 3.위험회피목적파생상품평가손익\n-\n-\n-\n(30,997)\n-\n(30,997)\n(6,792)\n(37,789)\n\xa0\xa0 4.관계기업의기타포괄손익\n-\n-\n-\n10,771\n-\n10,771\n-\n10,771\n\xa0\xa0 5.특별계정기타포괄손익\n-\n-\n-\n97,423\n-\n97,423\n-\n97,423\n\xa0\xa0 6.해외사업환산손익\n-\n-\n-\n24,758\n-\n24,758\n3,594\n28,352\n\xa0\xa0 7.순확정급여부채재측정요소\n-\n-\n-\n(26,059)\n-\n(26,059)\n(3,037)\n(29,096)\nⅡ.자본에 직접 인식된 내역\n\xa0\xa0 1.연차배당\n-\n-\n-\n-\n(475,873)\n(475,873)\n(37,530)\n(513,403)\n\xa0\xa0 2.지분법이익잉여금변동\n-\n-\n-\n-\n(30)\n(30)\n-\n(30)\n\xa0\xa0 3.기타\n-\n-\n-\n-\n-\n-\n2,963\n2,963\n2019. 12.31 (당기말)\n100,000 ==========\n125,115==========\n(2,116,955)==========\n21,509,453==========\n16,049,424 ==========\n35,667,037==========\n1,649,368==========\n37,316,405 ==========\n(4) 연결현금흐름표\n\xa0연\xa0\xa0 결\xa0\xa0 현\xa0\xa0 금\xa0\xa0 흐\xa0\xa0 름\xa0\xa0 표\n제64기\xa0 :\xa0 2019년 01월 01일부터 2019년 12월 31일까지\n제63기\xa0 :\xa0 2018년 01월 01일부터 2018년 12월 31일까지\n제62기\xa0 :\xa0 2017년 01월 01일부터 2017년 12월 31일까지\n삼성생명보험주식회사와 그 종속기업\n(단위 : 백만원)\n과\xa0 \xa0 \xa0 \xa0 \xa0 목\n제 64 (당) 기\n제 63 (전) 기\n제 62 (전전) 기\nⅠ.영업활동으로부터의 현금흐름\n\u3000\n8,644,450\n\u3000\n1,956,123\n\u3000\n1,608,186\n\xa0\xa0 1. 영업활동에서 창출된 현금흐름\n1,954,925\n\u3000\n-5,225,451\n\u3000\n-5,063,975\n\u3000\n\xa0 \xa0 \xa0 가. 당기순이익\n1,051,692\n\u3000\n1,733,710\n\u3000\n1,263,207\n\u3000\n\xa0 \xa0 \xa0 나. 손익조정사항\n740,025\n\u3000\n595,344\n\u3000\n3,447,084\n\u3000\n\xa0 \xa0 \xa0 다. 자산ㆍ부채의 증감\n163,208\n\u3000\n-7,554,505\n\u3000\n-9,774,266\n\u3000\n\xa0\xa0 2. 이자의 수취\n7,031,226\n\u3000\n7,051,418\n\u3000\n6,678,669\n\u3000\n\xa0\xa0 3. 이자의 지급\n-460,634\n\u3000\n-421,230\n\u3000\n-346,715\n\u3000\n\xa0\xa0 4. 배당금 수입\n1,043,877\n\u3000\n1,077,663\n\u3000\n773,515\n\u3000\n\xa0\xa0 5. 법인세부담액\n-924,944\n\u3000\n-526,277\n\u3000\n-433,308\n\u3000\nⅡ. 투자활동으로부터의 현금흐름\n\u3000\n-5,665,167\n\u3000\n-4,411,023\n\u3000\n-3,835,319\n\xa0\xa0 1. 매도가능금융자산의 처분\n8,474,108\n\u3000\n10,934,657\n\u3000\n8,471,322\n\u3000\n\xa0\xa0 2. 매도가능금융자산의 취득\n-14,859,272\n\u3000\n-15,149,903\n\u3000\n-12,506,795\n\u3000\n\xa0\xa0 3. 만기보유금융자산의 감소\n-\n\u3000\n16,315\n\u3000\n31,713\n\u3000\n\xa0\xa0 4. 위험회피목적파생상품자산의 정산\n-188,510\n\u3000\n36,612\n\u3000\n-68,383\n\u3000\n\xa0\xa0 5. 관계기업투자주식의 취득\n-47,368\n\u3000\n-10,151\n\u3000\n-91,537\n\u3000\n\xa0\xa0 6. 관계기업투자주식의 처분\n127,527\n\u3000\n3,592\n\u3000\n15,820\n\u3000\n\xa0\xa0 7. 투자부동산 및 유형자산의 취득\n-181,408\n\u3000\n-1,443,356\n\u3000\n-338,829\n\u3000\n\xa0\xa0 8. 투자부동산 및 유형자산의 처분\n772,523\n\u3000\n996,110\n\u3000\n867,021\n\u3000\n\xa0\xa0 9. 무형자산의 취득\n-93,278\n\u3000\n-154,289\n\u3000\n-286,261\n\u3000\n\xa0\xa0 10. 무형자산의 처분\n5,955\n\u3000\n5,369\n\u3000\n89,787\n\u3000\n\xa0\xa0 11. 연결범위변동 등\n324,556\n\u3000\n354,021\n\u3000\n-19,177\n\u3000\nⅢ. 재무활동으로부터의 현금흐름\n\u3000\n-1,206,623\n\u3000\n1,832,879\n\u3000\n1,558,230\n\xa0\xa0 1. 배당금 지급 등\n-521,714\n\u3000\n-448,514\n\u3000\n-255,018\n\u3000\n\xa0\xa0 2. 리스부채의 감소\n-143,325\n\u3000\n-\n\u3000\n-\n\u3000\n\xa0\xa0 3. 차입금의 차입\n5,570,706\n\u3000\n6,793,699\n\u3000\n10,637,000\n\u3000\n\xa0\xa0 4. 차입금의 상환\n-5,621,000\n\u3000\n-5,705,800\n\u3000\n-10,575,000\n\u3000\n\xa0\xa0 5. 사채의 발행\n11,527,926\n\u3000\n12,150,787\n\u3000\n39,536,584\n\u3000\n\xa0\xa0 6. 사채의 상환\n-12,415,905\n\u3000\n-11,548,693\n\u3000\n-38,232,267\n\u3000\n\xa0\xa0 7. 비지배지분의 증감\n396,689\n\u3000\n591,400\n\u3000\n446,931\n\u3000\nⅣ. 현금및현금성자산의 순증감\n\u3000\n1,772,660\n\u3000\n-622,021\n\u3000\n-668,903\nⅤ. 기초의 현금및현금성자산\n\u3000\n3,434,345\n\u3000\n4,055,552\n\u3000\n4,723,503\nⅥ. 외화표시 현금및현금성자산에 대한 환율변동효과\n\u3000\n644\n\u3000\n814\n\u3000\n952\nⅦ. 기말의 현금및현금성자산\n\u3000\n5,207,649\n\u3000\n3,434,345\n\u3000\n4,055,552\n']"
